10 employees
Zacharon Pharmaceuticals employs its glycobiology expertise to develop a new class of human therapeutics targeting glycans.
2004
$3.5M
from 2 investors over 2 rounds
Zacharon Pharmaceuticals raised undisclosed on November 25, 2008
Investors: National Institutes of Health
Zacharon Pharmaceuticals raised $3.5M on November 25, 2008
Investors: Avalon Venture